Article Information
History
- September 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Thomas W Laver1,
- Matthew N Wakeling1,
- Olivia Knox1,
- Kevin Colclough2,
- Caroline F Wright1,
- Sian Ellard1,
- Andrew T Hattersley1,
- Michael N Weedon1 and
- Kashyap A Patel1,*
- 1Institute of Biomedical and Clinical Science, University of Exeter, Exeter, UK
- 2Exeter Genomics Laboratory, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK
- ↵*Corresponding author: Dr Kashyap A Patel, Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, RLID building, level 3, Barrack road, Exeter, EX2 5DW,UK, Tel: 01392408237, Email: k.a.patel{at}exeter.ac.uk
Posted September 22, 2021.
Evaluation of evidence for pathogenicity demonstrates that BLK, KLF11 and PAX4 should not be included in diagnostic testing for MODY
